Treatment Comparison of Budesonide/Formoterol with Salmeterol/Fluticasone Propionate in Adults Aged ≥16 Years with Asthma
Author:
- 1 September 2010
- journal article
- research article
- Published by Springer Nature in Clinical Drug Investigation
- Vol. 30 (9) , 565-579
Abstract
Background Three fixed maintenance-dose inhaled corticosteroid/long-acting β2-agonist (ICS/LABA) combinations for the treatment of asthma are currently available: salmeterol/fluticasone propionate...Keywords
This publication has 35 references indexed in Scilit:
- Beclomethasone/formoterol vs fluticasone/salmeterol inhaled combination in moderate to severe asthmaAllergy, 2007
- Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbationsInternational Journal Of Clinical Practice, 2007
- Scientific rationale for using a single inhaler for asthma controlEuropean Respiratory Journal, 2007
- Beclomethasone/formoterolversusbudesonide/formoterol combination therapy in asthmaEuropean Respiratory Journal, 2006
- Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week studyClinical Therapeutics, 2006
- Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option?European Respiratory Journal, 2005
- Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthmaCurrent Medical Research and Opinion, 2004
- Effect of Inhaled Formoterol and Budesonide on Exacerbations of AsthmaNew England Journal of Medicine, 1997
- Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroidThe Lancet, 1994
- Determining a minimal important change in a disease-specific quality of life questionnaireJournal of Clinical Epidemiology, 1994